The NS1 protein of influenza A virus blocks RIG-I-Mediated activation of the noncanonical NF-κB pathway and p52/RelB-dependent gene expression in lung epithelial cells

Journal of Virology

Volumn 86, Issue 18, 2012, Pages 10211-10217

  Rückle, Andrea ^a   Haasbach, Emanuel ^b   Julkunen, Ilkka ^c   Planz, Oliver ^b   Ehrhardt, Christina ^a   Ludwig, Stephan ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MESSENGER RNA; NONSTRUCTURAL PROTEIN 1; PROTEIN P52; RETINOIC ACID INDUCIBLE PROTEIN I; TRANSCRIPTION FACTOR RELB;

ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE TARGETING; GENETIC ANALYSIS; INFLUENZA A; INFLUENZA VIRUS A; LUNG ALVEOLUS EPITHELIUM; MACROPHAGE INFLAMMATORY PROTEIN 3BETA GENE; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; VIRUS INDUCTION; VIRUS STRAIN;

CELL LINE; DEAD-BOX RNA HELICASES; EPITHELIAL CELLS; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; LUNG; NF-KAPPA B; NF-KAPPA B P52 SUBUNIT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELB; VIRAL NONSTRUCTURAL PROTEINS;

INFLUENZA A VIRUS;

EID: 84866156494     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00323-12     Document Type: Article

References (37)

1. Bonizzi G, et al. 2004. Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers. EMBO J. 23:4202-4210.
2. Coope HJ, et al. 2002. CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J. 21:5375-5385.
3. Cyster JG. 1999. Chemokines and cell migration in secondary lymphoid organs. Science 286:2098-2102.
4. Dejardin E. 2006. The alternative NF-κB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem. Pharmacol. 72:1161-1179.
5. Donelan NR, Basler CF, García-Sastre A. 2003. A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J. Virol. 77:13257-13266.
6. Droebner K, et al. 2010. The alternative NF-kappaB signalling pathway is a prerequisite for an appropriate immune response against lymphocytic choriomeningitis virus infection. Viral Immunol. 23:295-308.
7. Fleming-Canepa X, et al. 2011. Expression of duck CCL19 and CCL21 and CCR7 receptor in lymphoid and influenza-infected tissues. Mol. Immunol. 48:1950-1957.
8. Franzoso G, et al. 1998. Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187:147-159.
9. Gack MU, et al. 2009. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5:439-449.
10. García-Sastre A, et al. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324-330.
11. Guo Z, et al. 2007. NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am. J. Respir. Cell Mol. Biol. 36:263-269.
12. Kumar N, Xin Z-T, Liang Y, Ly H, Liang Y. 2008. NF-κB signaling differentially regulates influenza virus RNA synthesis. J. Virol. 82:9880-9889.
13. Liu P, Li K, Garofalo RP, Brasier AR. 2008. Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kappa B2 complexes via a novel retinoic acid-inducible gene-I{middle dot}NF-kappa B-inducing kinase signaling pathway. J. Biol. Chem. 283:23169-23178.
14. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
15. Ludwig S. 2011. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections. Biol. Chem. 392:837-847.
16. Ludwig S, Planz O. 2008. Influenza viruses and the NF-κB signaling pathway-towards a novel concept of antiviral therapy. Biol. Chem. 389:1307-1312.
17. Matsushima A, et al. 2001. Essential role of nuclear factor (NF)-κB-inducing kinase and inhibitor of κB (IκB) kinase α in Nf-κB activation through lymphotoxin β receptor, but not through tumor necrosis factor receptor I. J. Exp. Med. 193:631-636.
18. Mazur I, et al. 2007. Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity. Cell. Microbiol. 9:1683-1694.
19. Mibayashi M, et al. 2007. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J. Virol. 81:514-524.
20. Mordmüller B, Krappmann D, Esen M, Wegener E, Scheidereit C. 2003. Lymphotoxin and lipopolysaccharide induce NF-κB-p52 generation by a co-translational mechanism. EMBO Rep. 4:82-87.
21. M, Zohari S, Berg M. 2011. Non-structural protein 1 of avian influenza A viruses differentially inhibit NF-κB promoter activation. Virol. J. 8:383.
22. Nimmerjahn F, et al. 2004. Active NF-kappaB signalling is a prerequisite for influenza virus infection. J. Gen. Virol. 85:2347-2356.
23. Opitz B, et al. 2007. IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell. Microbiol. 9:930-938.
24. Pahl HL. 1999. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18:6853-6866.
25. Pauli E-K, et al. 2008. Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog. 4:e1000196. doi:10.1371/journal.ppat.1000196.
26. Pietilä TE, et al. 2007. Multiple NF-κB and IFN regulatory factor family transcription factors regulate CCL19 gene expression in human monocyte-derived dendritic cells. J. Immunol. 178:253-261.
27. Rangel-Moreno J, Carragher D, Randall TD. 2007. Role of lymphotoxin and homeostatic chemokines in the development and function of local lymphoid tissues in the respiratory tract. Inmunologia 26:13-28.
28. Schmolke M, Viemann D, Roth J, Ludwig S. 2009. Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptome. J. Immunol. 183:5180-5189.
29. Senftleben U, et al. 2001. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293:1495-1499.
30. Siebenlist U, Franzoso G, Brown K. 1994. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 10:405-455.
31. Wang X, et al. 2000. Influenza A virus NS1 protein prevents activation of NF-κB and induction of alpha/beta interferon. J. Virol. 74:11566-11573.
32. Wei L, et al. 2006. NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity. J. Biol. Chem. 281:11678-11684.
33. Wurzer WJ, et al. 2004. NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J. Biol. Chem. 279:30931-30937.
34. Wurzer WJ, et al. 2003. Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J. 22:2717-2728.
35. Xiao G, Fong A, Sun S-C. 2004. Induction of p100 processing by NF-κBinducing kinase involves docking IκB kinase α (IKKα) to p100 and IKKα-mediated phosphorylation. J. Biol. Chem. 279:30099-30105.
36. Xiao G, Harhaj EW, Sun S-C. 2001. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell 7:401-409.
37. Yin M-J, Yamamoto Y, Gaynor RB. 1998. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β. Nature 396:77-80.